您的位置: 首页 > 农业专利 > 详情页

Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof
专利权人:
Eureka Therapeutics; Inc.
发明人:
Liu, Hong,Zhang, Pengbo,Horan, Lucas,Xu, Yiyang,Staley, Binnaz K.,Liu, Lianxing,Yun, Hongruo
申请号:
AU2018258046
公开号:
AU2018258046A1
申请日:
2018.04.24
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The present application provides immune cells (such as T cells) comprising a chimeric antibody-T cell receptor (TCR) construct (caTCR) and a chimeric signaling receptor (CSR) construct. The caTCR comprises an antigen-binding module that specifically binds to a target antigen and a T cell receptor module (TCRM) capable of recruiting at least one TCR-associated signaling molecule, and the CSR comprises a ligand-binding domain that specifically binds to a target ligand and a co-stimulatory signaling domain capable of providing a stimulatory signal to the immune cell. Also provided are methods of making and using these cells.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充